NARI Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Inari Medical, Inc. Investors with Losses to Contact the Firm

Core Viewpoint - A securities class action lawsuit has been filed against Inari Medical, Inc. for alleged violations of federal securities laws, including fraudulent misrepresentations and omissions regarding the company's business and operations, impacting investors significantly during the class period from February 24, 2022, to February 28, 2024 [1][3]. Group 1: Legal Proceedings - The lawsuit is filed in the United States District Court for the Southern District of New York on behalf of investors who acquired Inari Medical common stock during the specified class period [1]. - The lead plaintiff deadline for the case is set for July 12, 2024, allowing affected investors to seek representation [2][5]. - The case is titled Michiana Area Electrical Workers' Pension Fund v. Inari Medical, Inc., et al., and is pending before Judge Jennifer Hutchison Rearden [5]. Group 2: Allegations and Impact - Inari Medical disclosed a civil investigative demand from the U.S. Department of Justice related to an investigation under the federal Anti-Kickback Statute and Civil False Claims Act, focusing on payments to healthcare professionals [3]. - Following the announcement of the investigation, Inari Medical's stock price fell by over $12 per share, a decline of 21%, from $58.26 to $46.12, resulting in a loss of approximately $700 million in market capitalization in a single trading day [4].